Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II trial of Tanhuo Bolus for acute ischemic stroke with phlegm-heat syndrome
CTR20261993Phase 2Active
- Sponsor
- Shanghai Kaibao Pharmaceutical
- Start
- Jul 2026
- Countries
- 1
01
Overview
A Phase 2 trial of Tanhuo Bolus in ischemic stroke, sponsored by Shanghai Kaibao Pharmaceutical. Started Jul 2026; status: active.
02
Drugs
Tanhuo Bolus
03
Conditions
ischemic stroke
Beyond the preview
Go deeper on CTR20261993.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20261993.